• Complete Genomics Tender Offer Finished

    GEN | BGI has successfully completed its tender offer for all outstanding shares of Complete Genomics, the Chinese firm said today.

    Mar 15, 2013

  • Study Launched to Measure Benefits, Risks of Genetic Information

    UCSF | University of California San Francisco is launching a four-year, $2.4 million project to analyze how physicians and patients in the general population, as well as those given whole genome sequencing results in a clinical trial, evaluate the benefits and risks of genetic information.

    Mar 15, 2013

  • Illumina to Pay $96m in Patent Damages

    News Brief | A judge in Tacoma, Washington, has ordered Illumina to pay $96 million in damages to Syntrix Biosystems for infringing upon its bead array patent.

    Mar 15, 2013

  • Genomics on the Big Screen

    NGS Leaders |It’s been over 15 years since Gattaca took genetics to the big screen and pushed the boundaries of the public’s imagination. But where is genomic science reflected in Hollywood today? Author and director Brett Bonowicz hopes to answer that with ThePerfect46, a film that explores where genetics and social networks overlap.

    Mar 15, 2013

  • Questions Linger Over Hopkins Research Study and Co-Author’s Apparent Suicide

    Washington Post | Apparent suicide and potential scandal are two unsavory elements surrounding a disputed article published by a noted Johns Hopkins research group in Nature six months ago.

    Mar 14, 2013

  • Steven Salzberg on Microbial Genomes, Open Access, Flu Shots and Gene Patents

    Bio-IT World | Steven Salzberg, computer scientist at Johns Hopkins University, is the winner of the 2013 Benjamin Franklin Award, presented annually by the Bioinformatics Organization. He spoke to Kevin Davies about the highlights of his lab’s research over the past 15 years and his philosophy on open-source and open access.

    Mar 14, 2013

  • 23andMe Founder on the Genetic Revolution

    Guardian | 23andMe founder, Anne Wojcicki, talks genomics and why everyone should get on board.

    Mar 13, 2013

  • Sirtris Closes, Other ReOrg Plans at GSK

    Bio-IT World Roundup | Yesteday afternoon GSK announced that it was closing its Sirtris Pharmaceuticals offices in Cambridge, Mass. Close on the heels of the announcement, rumors swirled about other GSK reorganizations.

    Mar 13, 2013

  • Nabsys Closes $20 Million Financing Round

    Bio-IT World | Nabsys has closed a $20 million Series D financing to support the commercial launch of the company’s positional sequencing system. The company previewed its pre-beta instrument at AGBT last month, giving early users the chance to see the technology at work.

    Mar 13, 2013

  • Nobel Laureate Jack Szostak on RNA Evolution, Drug Discovery Chemistry

    Bio-IT World Video | Jack Szostak, Nobel laureate, will be keynoting CHI’s Drug Discovery Chemistry conference in San Diego in April. In this video sneak peak, he and Bio-IT World editor Kevin Davies discuss the role of academics in R&D, the exciting world of macrocyclic peptides, and his plan to one-up evolution.

    Mar 13, 2013

  • HeLa Cells Sequenced

    Science 2.0 | HeLa cells, the immortal cell line commonly used for biologic research, have been sequenced, and the findings reveal vast differences between HeLa cells and normal human cells including number and structure of chromosomes.

    Mar 12, 2013

  • DNA Parts for Sale

    Nature | BIOFAB  is open for business, dealing in DNA parts--sequence sections that biologists can fit together to engineer cells.

    Mar 12, 2013

  • AWS Expands Elastic Beanstalk

    Computerworld | Amazon Web Services has expanded its Elastic Beanstalk to include Node.js. Now Node.js developers can run and scale their applications automatically in Elastic Beanstalk.

    Mar 12, 2013

  • Exploring Computational Biology as a Service: UberCloud Round Three

    Bio-IT World | Guest Commentary | The UberCloud CompBio Experiment explores the end-to-end process of accessing and using remote computing resources as a service, and learning how to resolve the many roadblocks. The experiment launches its third round on April 1, and the call is open now for participants.

    Mar 12, 2013

  • Sequencing and Sweet Sleep

    Not Exactly Rocket Science | When Lilly Grossman was one-and-a-half her parents might have thought the sleepness nights of babyhood were behind them. But Lilly starting suffering from muscle tremors at night that got progressively worse. For the last 13 years, Lilly has woken 20 to 30 times a night, shaking violently.

    Mar 11, 2013

  • The Real R&D Situation in China, India

    In the Pipeline | There's lots of talk about the biopharma investment in China and India, but it's less clear what part of the investment is actual R&D.

    Mar 8, 2013

  • Bio-IT World Expo Preview: Managing Big Data on the Genome’s 10th Anniversary

    Bio-IT World | This April welcomes the return of the Bio-IT World Expo in Boston (April 9-11, 2013). Over the course of three days, researchers from academia and industry will discuss themes of big data, cloud computing, trends in IT infrastructure, omics technologies, high-performance computing, data analytics and precision medicine, from the research realm to the clinical arena.

    Mar 7, 2013

  • Inaugural Gathering of Lab IT Forum Wins Big Pharma Interest

    Bio-IT World | WALTHAM, Mass.—The chief architects of a fledgling coalition of IT firms, consultancies and biopharma representatives declared their first meeting last week a promising success.

    Mar 6, 2013

  • Where Was Oxford at AGBT?

    Pathogens: Genes and Genomes | Oxford Nanopore was a conspicuous no-show on the program at the recent AGBT conference, in stark contrast to CTO Clive Brown’s blockbuster presentation 12 months earlier. But blogger Nick Loman snagged a bar-room chat with the reclusive Brown last month and reveals the major reason why the company has been so quiet lately: a complete redesign of the custom sensor microchip (ASIC) underlying the nanopore array.

    Mar 6, 2013

  • Nancy Kelley Steps Down as New York Genome Center Executive Director

    Bio-IT World | Nancy J. Kelley, the founding executive director of the New York Genome Center (NYGC) and the person most responsible for conceiving and bringing the ambitious institute to fruition, is stepping down from her leadership role.

    Mar 5, 2013